Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services – FDA 483, Dec 7, 2018
An FDA inspection of Lyophilization Services of New England, Inc. in Bedford, NH, a pharmaceutical manufacturer, revealed significant deficiencies across multiple quality systems. The firm failed to adequately manage quality processes, maintain appropriate equipment design and sanitization, thoroughly investigate product complaints, and establish procedures to prevent microbiological contamination of sterile drug products. These issues indicate a systemic breakdown in quality control and manufacturing practices.
- Inspection date
- December 7, 2018
- Product type
- drugs
ID · 94fbf236-bfa7-48b8-963a-791efec4a0d9
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.